Resveratrol shows efficacy in 2 diabetes studies

09/20/2013 | NutraIngredients

Type 2 diabetes patients who received oral hypoglycemic agents and resveratrol supplements attained significant improvements in body weight, oxidative stress and lipid profile compared with those who received only oral hypoglycemic agents, according to a study in the International Research Journal of Pharmacy. Another study, published in the journal Evidence-Based Complementary and Alternative Medicine, showed short-term use of resveratrol fared better than placebo in curbing blood glucose and insulin levels in patients with type 2 diabetes.

View Full Article in:

NutraIngredients

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ